PAPER Caselli RJ
SEARCH RESULTS
331256 RESULTS
PAPER Poil SS, de Haan W, van der Flier WM, Mansvelder HD, Scheltens P, Linkenkaer-Hansen K
Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage.
Front Aging Neurosci. 2013;5:58. PubMed: 24106478PAPER Arroyo-Anlló EM, Díaz JP, Gil R
Familiar music as an enhancer of self-consciousness in patients with Alzheimer's disease.
Biomed Res Int. 2013;2013:752965. PubMed: 24106716PAPER Velazquez P, Cribbs DH, Poulos TL, Tenner AJ
Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis.
Nat Med. 1997 Jan;3(1):77-9. PubMed: 8986745Rember TM
THERAPEUTICS 3,7-Bis(dimethylamino)phenothiazin-5-ium chloride TauRx Therapeutics Ltd Methylene Blue methylthioninium (MT) TRx-0014 Tau aggregation inhibitor (TAI) Small Molecule Tau The first trial known for Rember was a six-month Phase 2 study that ran between 2004
PAPER Rogers J, Schultz J, Brachova L, Lue LF, Webster S, Bradt B, Cooper NR, Moss DE
Complement activation and beta-amyloid-mediated neurotoxicity in Alzheimer's disease.
Res Immunol. 1992 Jul-Aug;143(6):624-30. PubMed: 1455054PAPER Weis JH, Morton CC, Bruns GA, Weis JJ, Klickstein LB, Wong WW, Fearon DT
A complement receptor locus: genes encoding C3b/C4b receptor and C3d/Epstein-Barr virus receptor map to 1q32.
J Immunol. 1987 Jan 1;138(1):312-5. PubMed: 3782802PAPER Birmingham DJ, Chen W, Liang G, Schmitt HC, Gavit K, Nagaraja HN
A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.
Immunology. 2003 Apr;108(4):531-8. PubMed: 12667215PAPER Wong WW
Structural and functional correlation of the human complement receptor type 1.
J Invest Dermatol. 1990 Jun;94(6 Suppl):64S-67S. PubMed: 2141049PAPER Liu D, Niu ZX
The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35).
Immunopharmacol Immunotoxicol. 2009;31(4):524-35. PubMed: 19874218Michael Wolfe on Trans-dominant negative effects of pathogenic PSEN1 mutations on γ-secretase activity and Aβ production.
COMMENT Ray Kelleher's response to my comment on the Heilig et al. study reveals a serious misunderstanding about how detergents are employed in the study of membrane proteins. The major problem is the conflation of the detergent's role in membrane solu
PAPER Arachea BT, Sun Z, Potente N, Malik R, Isailovic D, Viola RE